Related references
Note: Only part of the references are listed.Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease
Fadi S. Hanna Al-Shaikh et al.
JAMA NEUROLOGY (2020)
Evaluation of 11C-LSN3172176 as a Novel PET Tracer for Imaging M1 Muscarinic Acetylcholine Receptors in Nonhuman Primates
Nabeel B. Nabulsi et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Dementia in Down syndrome: unique insights for Alzheimer disease research
Ira T. Lott et al.
NATURE REVIEWS NEUROLOGY (2019)
The Brain NGF Metabolic Pathway in Health and in Alzheimer's Pathology
A. Claudio Cuello et al.
FRONTIERS IN NEUROSCIENCE (2019)
Advantages and disadvantages of the use of the CSF Amyloid (A) 42/40 ratio in the diagnosis of Alzheimer's Disease
Oskar Hansson et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
Daniel Alcolea et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis
M. Florencia Iulita et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
Daniel Alcolea et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
Harald Hampel et al.
BRAIN (2018)
Sex and Gender Differences in the Brain Cholinergic System and in the Response to Therapy of Alzheimer Disease with Cholinesterase Inhibitors
Ezio Giacobini et al.
CURRENT ALZHEIMER RESEARCH (2018)
Sex differences in Alzheimer disease - the gateway to precision medicine
Maria Teresa Ferretti et al.
NATURE REVIEWS NEUROLOGY (2018)
Compromise of cortical proNGF maturation causes selective retrograde atrophy in cholinergic nucleus basalis neurons
Simon Allard et al.
NEUROBIOLOGY OF AGING (2018)
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
Juan Fortea et al.
LANCET NEUROLOGY (2018)
Conformational characterization of nerve growth factor-β reveals that its regulatory pro-part domain stabilizes three loop regions in its mature part
Esben Trabjerg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18F]-FEOBV
M. Aghourian et al.
MOLECULAR PSYCHIATRY (2017)
Stop Alzheimer's before it starts
Eric McDade et al.
NATURE (2017)
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease
Maria Carmona-Iragui et al.
ALZHEIMERS & DEMENTIA (2017)
A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome
M. McCarron et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2017)
Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment
Michel J. Grothe et al.
CEREBRAL CORTEX (2016)
The NGF Metabolic Pathway in the CNS and its Dysregulation in Down Syndrome and Alzheimer's Disease
M. Florencia Iulita et al.
CURRENT ALZHEIMER RESEARCH (2016)
An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation
M. Florencia Iulita et al.
ALZHEIMERS & DEMENTIA (2016)
Cerebrospinal Fluid proNGF: A Putative Biomarker for Early Alzheimer's Disease
Scott E. Counts et al.
CURRENT ALZHEIMER RESEARCH (2016)
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology
Taylor W. Schmitz et al.
NATURE COMMUNICATIONS (2016)
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research
Sid E. O'Bryant et al.
ALZHEIMERS & DEMENTIA (2015)
The mature/pro nerve growth factor ratio is decreased in the brain of diabetic rats: Analysis by ELISA methods
Marzia Soligo et al.
BRAIN RESEARCH (2015)
A Pro-Nerve Growth Factor (proNGF) and NGF Binding Protein, α2-Macroglobulin, Differentially Regulates p75 and TrkA Receptors and Is Relevant to Neurodegeneration Ex Vivo and In Vivo
Pablo F. Barcelona et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
Julien Dumurgier et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Nerve growth factor metabolic dysfunction in Down's syndrome brains
M. Florencia Iulita et al.
BRAIN (2014)
Analysis of Matrix Metallo-Proteases and the Plasminogen System in Mild Cognitive Impairment and Alzheimer's Disease Cerebrospinal Fluid
Cecilia E. Hanzel et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Relationship Between β-Secretase, Inflammation and Core Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
Daniel Alcolea et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A Multicenter Study in Spain
Daniel Alcolea et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2013)
Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B
Benjamin L. Handen et al.
ALZHEIMERS & DEMENTIA (2012)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
Impact of the NGF Maturation and Degradation Pathway on the Cortical Cholinergic System Phenotype
Simon Allard et al.
JOURNAL OF NEUROSCIENCE (2012)
Reduction of Basal Forebrain Cholinergic System Parallels Cognitive Impairment in Patients at High Risk of Developing Alzheimer's Disease
Michel Grothe et al.
CEREBRAL CORTEX (2010)
Down Syndrome: From Understanding the Neurobiology to Therapy
Katheleen Gardiner et al.
JOURNAL OF NEUROSCIENCE (2010)
Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease
Martin A. Bruno et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive Impairment
Martin A. Bruno et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis
Veronica C. Ardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Expression of the serine protease inhibitor neuroserpin in cells of the human myeloid lineage
Sarah A. Kennedy et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade
MA Bruno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau
P Lewczuk et al.
NEUROBIOLOGY OF AGING (2004)
Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease
SY Peng et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
The cholinergic lesion of Alzheimer's disease: Pivotal factor or side show?
M Mesulam
LEARNING & MEMORY (2004)
Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions
K Gardiner et al.
GENE (2003)
Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to β-amyloid peptide42
A Maddalena et al.
ARCHIVES OF NEUROLOGY (2003)
Intraneuronal Aβ42 accumulation in Down syndrome brain
C Mori et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2002)
Annotation of human chromosome 21 for relevance to Down syndrome: Gene structure and expression analysis
K Gardiner et al.
GENOMICS (2002)
Commercial recombinant human β-nerve growth factor and adult rat dorsal root ganglia contain an identical molecular species of nerve growth factor prohormone
M Reinshagen et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
